Acceptability, safety, pharmacokinetics and effects on blood pressure of a daily dose of 0.025 to 0.135 milligram per kilogram of S 90652, a paediatric formulation of perindopril, in 2-16 years old hypertensive children - an open, non-comparative, 3-month multicentre study
DEC-NET Serial number IT559
Published online20/04/2006 14.36.00
Last updated11/08/2006 16.04.24
Other protocol ID numberCL2-90652-001
Current trial statusOpen (actively recruiting new participants)
Major Disease
(ICD9 class)		Essential hypertension
Experimental drug
PERINDOPRIL
Gender0
Age (range)

Eligibility criteria

Trial design/methodology
Phase2
Kind of studyEfficacy
Safety
Pharmacokinetics
DesignControlled


Sponsor name
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (Scientific organisation)

ISRCTN  EudraCT  2005-000077-22